Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Dermo-cosmetics Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Dermo-cosmetics Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Dermo-cosmetics Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Dermo-cosmetics Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 03 Jul 2021
  • Report ID: HLT 00233
  • Pages: 185
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

The dermo-cosmetic products are used to treat common skin problems such as psoriasis, eczema, acne, extreme sensitivity, and reactive skin. The rising number of incidences regarding skin disorders and lifestyle-related skin complaints have spurred the demand for dermo-cosmetic products in recent years. Growing awareness concerning skin reaction to adverse conditions such as pollution and sunlight has led to the emergence of dermo-cosmetic products. These products are not categorized under beauty products. However, they help enhance beauty. The global dermo-cosmetic market is expected to grow at a CAGR of 9.2% during the forecast period.

Top Driver: Surging Demand Among Millennials and Associated Benefits

The increasing number of young population and growing awareness about the benefits of dermo-cosmetic products among millennials are anticipated to drive the demand during the forecast period. Another major factor for the rise in demand for dermo-cosmetic products is the rising disposable income and growing consumer interest in wellness and health. The long-term benefits associated with dermo-cosmetic products are also expected to fuel the dermo-cosmetic market’s growth during the forecast period.

Skin Care Products Segment to Make Crucial Contribution to Growth of Global Dermo-Cosmetic Market

The global Dermo-cosmetic market can be segmented on the basis of type which includes Skin Care Products Hair Care Products, Eye Care Products, Others. The skin care segment is expected to dominate the market due to rising awareness about skin care routine among the people. On the basis of application, the market can be segmented as Retail Pharmacy, Hospital Pharmacy, Online Sales.

Rising Investments in Dermo-cosmetics to Benefit Asia Pacific Market

The Asia Pacific region is anticipated to gain highest revenue shares due to the surge in the investments over the products that improve the aesthetics in the forecast period. Furthermore, the increase in the   disposable income of the individuals would help the industry propel in the forecast period. The rise in the incidences of skin diseases coupled with the surge in the need for better aesthetics would help the industry to gain significantly in the near future.

Players to Focus on Dermo-Cosmetic Market

The global market is expected to stay fragmented with the increase in the number of new entrants in the coming years. Allergan plc, L’Oreal S.A., BSN medical GmbH, Procter & Gamble Co., Johnson & Johnson, Jan Marini Skin Research Inc, Unilever plc, ZO Skin Health Inc., La Prairie, Valeant Pharmaceuticals Inc., Revive, Shiseido Group, Glo Skin Beauty Bioelements, Amorepacific Corporation, and PCA Skin among others could be at the forefront of the competition in the global market.

L’Oreal S.A.: In April 2019, the local arm of the world’s largest cosmetics company, L’Oréal, is scouting for acquisitions in the skin and make-up market in India, said a top company executive, adding that it seeks to capitalize on the country’s rising demand for beauty products.

BSN medical: In April 2017, SCA’s acquisition of BSN medical, a leading medical solutions company, has been closed. The company develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price for the shares amounts to EUR 1,400m and takeover of net debt to approximately EUR 1,340m1).

Scope of the Report

By Type

  • Skin Care Products
  • Hair Care Products
  • Eye Care Products
  • Others

By Application

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Sales

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report